Work

A phase II study of PXD101 (belinostat) in relapsed and refractory aggressive B-cell lymphomas (rel/ref ABCL): SWOG S0520.

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.15_suppl.e18536

Authors: Daniel Oscar Persky, Steven H. Bernstein, Bryan H. Goldman, Lisa M. Rimsza, Richard I. Fisher, Thomas P. Miller

Institutions: University of Arizona Cancer Center, University of Rochester Medicine, SWOG Cancer Research Network, University of Arizona, University of Rochester

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2601229823

Cites:

Cited by: 7

Related to: 10